Levels of fractional exhaled nitric oxide (FeNO) — a measure of how much nitric oxide a person exhales — may…
Articles by Patricia Inácio, PhD
Claritas Pharmaceuticals now has exclusive worldwide rights to develop and market R-107 — a liquid form of nitric oxide…
Elevated levels of three blood proteins — AMBP, LPL and glyoxalase I — may help identify and distinguish people with…
OxiWear has raised $1.25 million in funding to support the final steps in the commercialization of its ear-wearable device,…
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Yutrepia (treprostinil), previously known as LIQ861, as an…
A six-month at-home rehabilitation program can help improve respiratory muscle strength and physical endurance, while promoting better quality of life,…
PulmoSIM Therapeutics has joined with scientists at National Jewish Health hospital and Brown University to advance PT001, its investigational…
U.S. veterans infected with the human immunodeficiency virus (HIV) — the virus that causes AIDS — are at higher risk…
Joining support groups — meeting people with common experiences and concerns who can provide emotional reassurance — for pulmonary…
Despite a high-risk of serious complications, 10 women with moderate to severe pulmonary arterial hypertension (PAH) had a successful…
Treatment with a single medication (monotherapy) may be sufficient to help manage people with “atypical” pulmonary arterial hypertension (PAH),…
Ahead of this year’s Rare Disease Week on Capitol Hill, held virtually July 14–22, the EveryLife Foundation will…